Kamakar , S and Lal , G (2021) Role of serotonin receptor signaling in cancer cells and anti-tumor immunity. Theranostics . 2021 Mar 11;11(11):5296-5312., 11 (11). pp. 5296-5312.

Text 131.-1 Dr. Lal G. (Theranostics) author copy.pdf Restricted to Repository staff only Download (15Mb) | Request a copy

Abstract

Serotonin or 5-hydroxytryptamine (5-HT) is a neurotransmitter known to affect emotion, behavior, and cognition, and its effects are mostly studied in neurological diseases. The crosstalk between the immune cells and the nervous system through serotonin and its receptors (5-HTRs) in the tumor microenvironment and the secondary lymphoid organs are known to affect cancer pathogenesis. However, the molecular mechanism of - alteration in the phenotype and function of - innate and adaptive immune cells by serotonin is not well explored. In this review, we discuss how serotonin and serotonin receptors modulate the phenotype and function of various immune cells, and how the 5-HT-5-HTR axis modulates antitumor immunity. Understanding how 5-HT and immune signaling are involved in tumor immunity could help improve therapeutic strategies to control cancer progression and metastasis.

Item Type:	Article
Subjects:	Infection and Immunity
Depositing User:	Mr. Rameshwar Nema
Date Deposited:	19 Apr 2021 11:50
Last Modified:	29 Nov 2021 12:11
URI:	http://nccs.sciencecentral.in/id/eprint/922

Actions (login required)

View Item